Prediction of percutaneous absorption in human using three-dimensional human cultured epidermis LabCyte EPI-MODEL

Biological and Pharmaceutical Bulletin

Volumn 35, Issue 3, 2012, Pages 362-368

  Hikima, Tomohiro ^a   Kaneda, Noriaki ^a   Matsuo, Kyouhei ^a   Tojo, Kakuji ^a  

^a KYUSHU INSTITUTE OF TECHNOLOGY   (Japan)

Author keywords

Hairless mouse; In silico correlation; LabCyte EPI MODEL; Reconstructed epidermis

Indexed keywords

2 NAPHTHOL; CAFFEINE; CYANOCOBALAMIN; ESTRADIOL; ETHINYLESTRADIOL; HYDROCORTISONE; INDOMETACIN; KETOPROFEN; KETOTIFEN FUMARATE; LOMEFLOXACIN; NICOTINE; NORETHISTERONE; PREDNISOLONE; PROPIVERINE; SALICYLIC ACID METHYL ESTER; TESTOSTERONE; TIMOLOL MALEATE; TULOBUTEROL; VERAPAMIL;

ANIMAL TISSUE; ARTICLE; COMPUTER MODEL; CULTURED HUMAN EPIDERMIS; DIFFUSION COEFFICIENT; DRUG BLOOD LEVEL; EPIDERMIS; FEMALE; HAIRLESS MOUSE; HUMAN; HUMAN TISSUE; IN VITRO STUDY; LIPOPHILICITY; MOLECULAR WEIGHT; MOUSE; NONHUMAN; PARTITION COEFFICIENT; PREDICTION; SKIN ABSORPTION; SKIN CULTURE; STATISTICAL MODEL;

ANIMALS; COMPUTER SIMULATION; FEMALE; HUMANS; MICE; MICE, HAIRLESS; MODELS, BIOLOGICAL; PHARMACEUTICAL PREPARATIONS; SKIN; SKIN ABSORPTION; STEROIDS;

EID: 84857877339     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.35.362     Document Type: Article

References (31)

1. EC. 7th Amendment to the EC cosmetic Directive (L66/26-35). 27th February 2003, Brussels, Belgium (2003).
2. Zuang V, Balls M, Botham PA, Coquette A, Corsini E, Curren RD, Elliott GR, Fentem JH, Heylings JR, Liebsch M, Medina J, Roguet R, van de Sandt JJ, Wiemann C, Worth AP. Follow-up to the ECVAM prevalidation study on in vitro tests for acute skin irritation. The European Centre for the Validation of Alternative Methods Skin Irritation Task Force Report 2. Altern. Lab. Anim., 30, 109-129 (2002).
3. Fentem JH. Validation of in vitro tests for skin corrosivity. ALTEX, 16, 150-153 (1999).
4. Netzlaff F, Kaca M, Bock U, Haltner-Ukomadu E, Meiers P, Lehr CM, Schaefer UF. Permeability of the reconstructed human epidermis model Episkin® in comparison to various human skin preparations. Eur. J. Pharm. Biopharm., 66, 127-134 (2007).
5. Asbill C, Kim N, El-Kattan A, Creek K, Wertz P, Michniak B. Evaluation of a human bio-engineered skin equivalent for drug permeation studies. Pharm. Res., 17, 1092-1097 (2000).
6. Lotte C, Patouillet C, Zanini M, Messager A, Roguet R. Permeation and skin absorption: reproducibility of various industrial reconstructed human skin models. Skin Pharmacol. Appl. Skin Physiol., 15 (Suppl. 1), 18-30 (2002).
7. OECD. Skin absorption: in vitro method. Test Guideline 428 (2004).
8. Tojo K. Mathematical Models of Transdermal and Topical Drug Delivery, 2nd ed., Biocom Systems Inc., Fukuoka (2005).
9. Simon GA, Maibach HI. Relevance of hairless mouse as an experimental model of percutaneous penetration in man. Skin Pharmacol. Appl. Skin Physiol., 11, 80-86 (1998).
10. Katoh M, Hamajima F, Ogasawara T, Hata K. Assessment of human epidermal model LabCyte EPI-MODEL for in vitro skin irritation testing according to European Centre for the Validation of Alternative Methods (ECVAM)-validated protocol. J. Toxicol. Sci., 34, 327-334 (2009).
11. Tojo K. Design and calibration of in vitro permeation apparatus. Transdermal controlled systemic medications. (Chien YW ed.) Mercel Dekker, Inc., New York, pp. 127-158 (1987).
12. Hikima T, Maibach HI. Skin penetration flux and lag-time of steroids across hydrated and dehydrated human skin in vitro. Biol. Pharm. Bull., 29, 2270-2273 (2006).
13. Kaneda N. The use of three-dimentional human reconstructed epidermis for skin permeation study in vitro. M.S. Thesis, Kyushu Institute of Technology (2010).
14. Weinberg WC, Goodman LV, George C, Morgan DL, Ledbetter S, Yuspa SH, Lichti U. Reconstitution of hair follicle development in vivo: determination of follicle formation, hair growth, and hair quality by dermal cells. J. Invest. Dermatol., 100, 229-236 (1993).
15. Illel B, Schaefer H, Wepierre J, Doucet O. Follicles play an important role in percutaneous absorption. J. Pharm. Sci., 80, 424-427 (1991).
16. Essa EA, Bonner MC, Barry BW. Human skin sandwich for assessing shunt route penetration during passive and iontophoretic drug and liposome delivery. J. Pharm. Pharmacol., 54, 1481-1490 (2002).
17. Frum Y, Eccleston GM, Meidan VM. Factors influencing hydrocortisone permeation into human hair follicles: use of the skin sandwich system. Int. J. Pharm., 358, 144-150 (2008).
18. Hikima T, Ashizuka Y, Natakeyama N, Tojo K. In vitro examination of drug reservoir effect in epidermis. Yakuzaigaku, 60 (Suppl.), 259 (2005).
19. Schmook FP, Meingassner JG, Billich A. Comparison of human skin or epidermis models with human and animal skin in in-vitro percutaneous absorption. Int. J. Pharm., 215, 51-56 (2001).
20. Schäfer-Korting M, Bock U, Diembeck W, Düsing HJ, Gamer A, Haltner-Ukomadu E, Hoffmann C, Kaca M, Kamp H, Kersen S, Kietzmann M, Korting HC, Krächter HU, Lehr CM, Liebsch M, Mehling A, Müller-Goymann C, Netzlaff F, Niedorf F, Rübbelke MK, Schäfer U, Schmidt E, Schreiber S, Spielmann H, Vuia A, Weimer M. The use of reconstructed human epidermis for skin absorption testing: Results of the validation study. Altern. Lab. Anim., 36, 161-187 (2008).
21. Ponec M, Boelsma E, Weerheim A, Mulder A, Bouwstra J, Mommaas M. Lipid and ultrastructural characterization of reconstructed skin models. Int. J. Pharm., 203, 211-225 (2000).
22. Batheja P, Song Y, Wertz P, Michniak-Kohn B. Effects of growth conditions on the barrier properties of a human skin equivalent. Pharm. Res., 26, 1689-1700 (2009).
23. Panchagnula R, Stemmer K, Ritschel WA. Animal models for transdermal drug delivery. Methods Find. Exp. Clin. Pharmacol., 19, 335-341 (1997).
24. Rohr UD, Saeger-Lorenz K. 17β-Estradiol matrixpatch removal and reapplication in postmenopausal women: theoretical predictions with an oscillating diffusion coefficient model. J. Pharm. Sci., 91, 822-844 (2002).
25. Balfour JA, Heel RC. Transdermal estradiol. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of menopausal complaints. Drugs, 40, 561-582 (1990).
26. Gilman AG, Goodman LS, Rall TW, Murad F. The Pharmacological Basis of Therapeutics. Micmillan, New York (1985).
27. Hansch C, Leo A. Substituent Constants for Correlation Analysis in Chemistry and Biology. John Wiley & Sons, New York (1979).
28. Tashiro Y, Shichibe S, Kato Y, Hayakawa E, Itoh K. Effect of lipophilicity on in vivo iontophoretic delivery. I. NSAIDs. Biol. Pharm. Bull., 24, 278-283 (2001).
29. Hikima T, Ohsumi S, Shirouzu K, Tojo K. Mechanisms of synergistic skin penetration by sonophoresis and iontophoresis. Biol. Pharm. Bull., 32, 905-909 (2009).
30. Ogiso T, Iwaki M, Hirota T, Tanino T, Muraoka O. Comparison of the in vitro skin penetration of propiverine with that of terodiline. Biol. Pharm. Bull., 18, 968-975 (1995).
31. Rodgers T, Rowland M. Physiologically based pharmacokinetic modelling 2: predicting the tissue distribution of acids, very weak bases, neutrals and zwitterions. J. Pharm. Sci., 95, 1238-1257 (2006).